- Home
- IAG vs ALVO Comparison
IAG vs ALVO Comparison
Compare IAG & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAG
- ALVO
- Stock Information
- Founded
- IAG 1990
- ALVO 2013
- Country
- IAG Canada
- ALVO Luxembourg
- Employees
- IAG 5300
- ALVO N/A
- Industry
- IAG Precious Metals
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- IAG Basic Materials
- ALVO Health Care
- Exchange
- IAG Nasdaq
- ALVO Nasdaq
- Market Cap
- IAG 4.5B
- ALVO 3.4B
- IPO Year
- IAG 1996
- ALVO N/A
- Fundamental
- Price
- IAG $7.03
- ALVO $7.94
- Analyst Decision
- IAG Buy
- ALVO Buy
- Analyst Count
- IAG 7
- ALVO 1
- Target Price
- IAG $7.77
- ALVO $18.00
- AVG Volume (30 Days)
- IAG 17.7M
- ALVO 151.4K
- Earning Date
- IAG 05-06-2025
- ALVO 05-20-2025
- Dividend Yield
- IAG N/A
- ALVO N/A
- EPS Growth
- IAG 677.20
- ALVO N/A
- EPS
- IAG 1.50
- ALVO N/A
- Revenue
- IAG $1,633,000,000.00
- ALVO $491,978,000.00
- Revenue This Year
- IAG $38.27
- ALVO $33.92
- Revenue Next Year
- IAG $6.29
- ALVO $45.74
- P/E Ratio
- IAG $4.69
- ALVO N/A
- Revenue Growth
- IAG 65.43
- ALVO 426.85
- 52 Week Low
- IAG $3.44
- ALVO $7.35
- 52 Week High
- IAG $8.38
- ALVO $14.76
- Technical
- Relative Strength Index (RSI)
- IAG 53.90
- ALVO 29.94
- Support Level
- IAG $7.06
- ALVO $8.04
- Resistance Level
- IAG $7.47
- ALVO $8.75
- Average True Range (ATR)
- IAG 0.43
- ALVO 0.56
- MACD
- IAG -0.00
- ALVO 0.05
- Stochastic Oscillator
- IAG 55.45
- ALVO 36.20
About IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.